Introduction
The organophosphorus ester, triphenyl phosphite (TPP), which is widely used as a chemical intermediate for phosphite stabilizers and antioxidants in plastics and rubber industries1), is known to produce delayed neurotoxic damage in cats, rats, and hens that appears several days after acute toxicity has disappeared2). It is thought that this TPP-induced delayed neurotoxicity (TPP-DN) is similar, although not identical, to classical organophosphate induced delayed neurotoxicity (OPIDN). The main differences between TPP-DN and OPIDN are in clinical appearance3,4), in pathological lesions Even in sensitive species young animals are insensitive to OPIDN6,7). Neurotoxicity target esterase (NTE) is thought to be responsible for OPIDN7), and differences in the recovery rate of inhibited NTE have been observed between young and adult chickens8,9).
.
In a previous study, we observed that the susceptibility of chickens to TPP-DN, like their susceptibility to OPIDN, was age-dependent10).
Although a relationship between age-specific susceptibility and the pharmacokinetics of TPP was shown in that study, the relationship between clinical appearance and histopathological lesions still remained unclear. Furthermore, in that study, differences in NTE inhibition between sensitive and insensitive age groups were not examined.
In the present study, histopathological lesions and the degree of NTE inhibition both in vivo and in vitro are compared between young and adult chickens after TPP administration. Then, the differences between TPP-DN and OPIDN are discussed.
Materials and Methods

Chemicals
Technical grade triphenyl phosphite (TPP, 95% pure), obtained from Wako Pure Chem. Co. (Tokyo, Japan), was used after recrystallization.
Paraoxon was purchased from Sigma Chemical Co. (St. Louis, USA). Mipafox and phenyl valerate were synthesized by Dr S. Sayama, Dept. of Chemistry, Fukushima Medical College (Fukushima, Japan), by the method described by Johnson11), with his personal advice. All other chemicals and reagents were of the highest purity commercially available.
Animals and treatment
Female chickens (Gallus gallus domesticus) aged 65 days and 24 months were used. Intravenous solutions of TPP were prepared by dissolving the chemical in dimethylsulf oxide, Tween 80, and saline (1:1:3); the final concentrations of TPP were adjusted so that injection volume was 2ml/kg. The solution was prepared less than one hour prior to administration.
TPP solution (12.5, 25, or 50mg/kg) was injected into a wing vein. Feed and water were freely accessible at all times. The birds were housed in
Clinical evaluation
From one week before to one day after intravenous administration of 50mg/kg of TPP, birds were housed in individual cages; they were then removed to large cages to observe clinical signs. Abnormalities of gait and behavior were observed for 14 days after treatment. The system used to note the progress of clinical signs has four grades: + (mild ataxia), ++ (severe ataxia), +++ (mild paralysis), and ++++ (severe paralysis)12). Histopathology Birds dosed with 50mg/kg of TPP were killed by electric shock (200v) 14 days after administration. Spinal cords and sciatic nerves were dissected and fixed in 10% phosphate-buffered formalin and embedded in paraffin. Longitudinal and transverse sections were examined by light microscope using hematoxlin and eosin stain and Kluver-Barrera stain. NTE and ACh-E inhibition following iv administration TPP-treated birds were assayed for brain, spinal cord, and sciatic nerve NTE and acetylcholine esterase (ACh-E) activities at 24 and 48 hours, and 7 days postexposure. Non-treated birds were also assayed as controls. Birds were killed by electric shock and brains and spinal cords at thoracic lumbar levels were rapidly dissected. Sciatic nerves were also dissected, and extraneous fat and connective tissue buffer. NTE activity in brain and spinal cord was measured by Johnson's method11), as modified by Soliman et al.13) , with the reaction volume reduced to one half that in the original method. NTE activity in sciatic nerves was measured by the method of Carrington and Abou-Donia8).
For the NTE assay, incubation was performed with gentle agitation so as to keep the reaction solution homogenous.
ACh-E activity was measured by the method of Ellman et al.14).
NTE inhibition in vitro
The brains and spinal cords of untreated chickens were prepared as above. Several different concentrations of TPP were used to inhibit NTE activity as outlined below. TPP was dissolved in dimethylformamide,
Tween 80, and water-free pure ethanol (1:1:8) to make a 10-2M solution, which
Results
Clinical appearance and histopathological lesions Immediately after i. v. administration of 50mg/kg of TPP, all birds in both age groups showed tachypnea and hypoactivity; they appeared normal within a half an hour. Table 1 shows clinical and histopathological damage after recovering from the acute symptom. Six to seven days after TPP administration, all of the 24-month-old chickens showed abnormal gait; at 14 days postexposure they were judged to have mild or severe ataxia. All of the 4 chickens observed showed mild axonal damage in the sciatic nerve and spinal cord at lumbar and cervical regions. The axonal damage of the spinal cord was shown primarily in the ventral column. Swollen, chromatolitic cells were occasionally observed in the lumbar region in two birds and in the cervical region of one bird. In the 65-day-old chickens, on the other hand, only 3 of 6 had mild abnormalities of gait, and they were not judged to be ataxic. Pathological damage was shown in the sciatic nerve of only one of the 4 chicks observed, but only in one fragmented axon in all the sections observed. Figure 1 shows a microscopic picture of the transversal section at the lumbar level for one chicken in each age group. NTE activity Figure 2 shows a comparison of nervous tissue NTE activity in 65-day-old and 24-month-old chickens before and after i. v. administration of 12.5, 25, and 50mg/kg of TPP. Before administration (control), ACh-E activity Table 2 shows ACh-E activity in the brain, spinal cord, and sciatic nerves of 65-day-old and 24-month-old chickens after i. v. administration of 12.5, 25, and 50mg/kg of TPP. Inhibition of ACh-E activity was small or was not detected in any of the three tissues at 24 and 48 hours after administration of each concentration of TPP.
Discussion
Birds in both the young and the adult groups showed tachypnea and hypoactivity just after intravenous administration of TPP, but no bird showed cholinergic signs. These findings corresponded well with the results for ACh-E activity, which showed little inhibition after TPP administration (Table 2 ). In rats treated with two s. c. injections of TPP with a one week-interval, brain ACh-E showed a maximum inhibition that was only 30% of control values at 4hr after the second dose15). In 31P nuclear magnetic resonance studies it was found that the acute conversion of TPP to diphenyl phosphonic acid after s. c. dosing was accompanied by acute lethality to chickens16). The occurrence of diphenyl phosphonic acid and/or phenol may be responsible for the acute toxicity of TPP. Intravenous administration would studies10,12) showed that, using clinical criteria such as their susceptibility to OPIDN, the susceptibility of chickens to TPP-DN was age-dependent. In this study, the age-dependency was confirmed, not only clinically but also histopathologically, that is, pathological lesions in young chickens which showed negligible or no clinical signs were only marginal, while pathological lesions in adult chickens which showed clear ataxia were obvious (Table 1, Fig. 1) . After one or two s. c. doses of 1000mg/kg of TPP, one-week-old chicks developed ataxia and paralysis; this was accompanied by definitive histopathological lesions20). These findings indicate that if enough of the chemical reaches the target then neurotoxic damage develops. Our previous report clearly suggested that the age-specific susceptibility to TPP is related to the difference of the tissue load, which derives in part from differing levels of metabolic activity in the liver and/or other tissues10). Abou-Donia and Nomeir21) also suggested that quantitative differences in the metabolic biotransformation pathways and pharmacokinetic profiles of organophosphorus compounds may play a role in age-and species-selective delayed neurotoxic effects.
In chickens, TPP inhibited NTE, which has been thought a putative target enzyme for OPIDN, both in vivo and in vitro. The dose-response curve for NTE inhibition was also shown to correlate with the neurotoxicity of TPP22). The results of this study support these findings, since at 24 and 48h postexposure the degree of NTE inhibition was slightly smaller in young chicks, which showed less neurological damage than adult hens (Table 1, Fig. 2) . The difference of NTE inhibition levels at 24h and 48h postexposure in the two age groups probably derived from the difference of metabolic activity10), since NTE inhibition following TPP administration is caused by unchanged TPP23), and the property of inhibition in vitro was almost the same in the two age groups (Fig. 3) . Nevertheless, the difference in the NTE inhibition levels was not so large, and NTE activity in all the three tissues of young birds inhibited more than 70% of the control, which is the level thought to predict the following neuropathy7), at 24 and 48h after administration of 50mg/kg of TPP (Fig. 2) . Olson et al. 24 ) also reported that administration of TOCP, or its active metabolite TSP (o-tolyl saligenin phosphate), to 4-week-old chicks resulted in the inhibition of more than 75% of NTE activity and more than 66% in the sciatic nerve, but no birds displayed clinical signs typical of OPIDN.
Johnson and Barnes18) found no significant difference between the rate of recovery of NTE in hen and chick brains. In this study, the recovery of NTE in chicks and hens was compared not only in the brain and spinal cord, but also in the sciatic nerve, since the degree of NTE inhibition in the brain after administration of organophosphorus compounds may not be a good monitor for this enzyme in parts of the nervous system where axonal degeneration actually develops25). The present data demonstrated that the difference of NTE recovery was obvious in the sciatic nerve but was not so clear in the brain (Fig. 2) . Moretto et al. 9 ) also reported that after DFP treatment the recovery of NTE in the sciatic nerves of younger chicks was faster than their older counterparts.
According to Carrington and Abou-Donia8), NTE recovery was faster in the brains of the chicks than in those of hens following DFP administration. Johnson's working hypothesis18), that in chickens it is not in the brain but in the sciatic nerve that NTE inhibition does not persist, due either to more rapid reactivation or synthesis of a new enzyme, is still operative. In this study, the difference of NTE recovery was obvious only in the sciatic nerve; however, our previous report10) showed that the disappearance of TPP from the brain, spinal cord and sciatic nerve was faster in young chickens than in old chickens. These results suggest that, in addition to the difference of the metabolic activity other mechanisms also contribute to the difference of NTE recovery. If newly synthesized NTE is continually transported to and restored in peripheral nerves, the differential recovery of NTE in sciatic nerves in different age groups can be simply understood, that is, NTE is transported by fast axonal transport26), so that the length of the peripheral nerves may be related to the differences in recovery.
Abou-Donia and Lapadula20) proposed OPIDN as type I and TPP-DN as type II organophosphorus ester-induced delayed neurotoxicity. However, as mentioned above, the age-specificity and the course of NTE inhibition in the present study are virtually identical to those obtained in other studies with compounds that cause OPIDN (type I). This would suggest that an i. v. dose of TPP causes OPIDN (type I) in the hen. Other effects, which make the characteristics of the type II delayed neurotoxicity, observed in the hen5) and rat3,4) following subcutaneous administration may result from diphenyl phosphonic acid, phenol or some other hydrolytic product. In other words, TPP itself causes OPIDN (type I) and hydrolytic products are responsible for additional effects characteristic of type II delayed neurotoxicity. The i. v. dose used in this study might minimize the effect of hydrolytic products.
Summary
Triphenyl phosphite (TPP)-induced delayed neurotoxicity, which is thought to resemble but somewhat differ from classical organophosphate-induced delayed neurotoxicity (OPIDN), is known to be age-dependent. The relationship between clinical appearance and histopathological lesions, and the inhibition of neurotoxicity target esterase (NTE) in nervous tissues were compared in young and adult chickens after i. v. administration of TPP. NTE inhibition by TPP in vitro was also compared between the two age groups. Fourteen days after i. v. administration of TPP (50mg/kg), adult chickens (24 months old) showed obvious histopathological lesions as well as obvious clinical neurological signs. On the other hand, young chickens (65 days old) showed few histopathological lesions and only marginal neurological signs. NTE activity in brain, spinal cord, and sciatic nerves was inhibited in a dose-dependent manner in both age groups. While inhibition tended to be mild in the younger chickens, the level of activity was less than 30% of the normal value in all three tissues at 24 hours after administration of 50mg/kg of TPP (14% vs. 8% in brain, 15% vs. 9% in spinal cord and 13% vs. 14% in sciatic nerves). Recovery of NTE activity in the sciatic nerves was faster in the younger chickens. The IC50 of TPP on brain (6.67 groups.
These results confirmed age-specific susceptibility to TPP, not only clinically but also histopathologically, and, suggested that the differences in both TPP metabolism and NTE recovery are related to and/or contribute to this age specificity.
Judging from the age specificity and the figure of NTE inhibition, the delayed neurotoxicity produced by an i. 
